Temporal trends in the initiation of glucose-lowering medications after a first-time myocardial infarction - a nationwide study between 1997 and 2006

BACKGROUND: Type 2 diabetes is a well-established risk factor for cardiovascular disease and is common among patients with acute myocardial infarction (MI). The extent to which patients with first-time MI develop diabetes requiring glucose-lowering medications (GLM) is largely unknown. The aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Norgaard, Mette L, Andersson, Charlotte, Hansen, Peter Riis, Andersen, Søren S, Vaag, Allan, Schramm, Tina K, Folke, Fredrik, Køber, Lars, Torp-Pedersen, Christian, Gislason, Gunnar H
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031215/
https://www.ncbi.nlm.nih.gov/pubmed/21247456
http://dx.doi.org/10.1186/1475-2840-10-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031215/
https://www.ncbi.nlm.nih.gov/pubmed/21247456
http://dx.doi.org/10.1186/1475-2840-10-5

Ejemplares similares